Sahajanand Medical Technologies
NSE: SMT · ISIN INE356Y01018 · Healthcare
₹499.70−35.00 (−6.55%)
Monday 9 November, 12:19 IST. Delayed. Source: Yahoo Finance.
Price chart
₹499.70 −35.00 (−6.55%) today
The day
- Previous close
- ₹534.70
- Open
- ₹537.00
- Day high
- ₹537.90
- Day low
- ₹496.80
Listed on NSE since 23 October 2026.
Key numbers
- Market value
- ₹5,079.29 Cr
- P/E (trailing)
- 70.18
- EPS (trailing)
- ₹7.12
- Price to book
- 7.05
- Dividend yield
- 0.00%
- Return on equity
- 10.7%
- Debt to equity
- 0.49
- Profit margin
- 5.4%
- Volume today
- 3.68 L
- Average volume
- 50.23 L
Source: Yahoo Finance. Ratios use the latest reported (trailing twelve-month) figures.
Revenue and profit
| Year | Revenue | Net profit |
|---|---|---|
| FY24 | ₹901.60 Cr | ₹-7.35 Cr |
| FY25 | ₹1,024.88 Cr | ₹25.15 Cr |
| FY26 | ₹1,210.50 Cr | ₹69.08 Cr |
Source: Yahoo Finance, from annual reports. Consolidated where reported.
Quarterly results
| Quarter | Revenue | Net profit | Profit vs year ago |
|---|---|---|---|
| Q2 FY27Jul–Sep 2026 | ₹373 Cr | ₹26 Cr | – |
Source: Sahajanand Medical Technologies’s results filed with NSE, consolidated (the whole group). Net profit is the share of Sahajanand Medical Technologies’s own shareholders where the filing separates it. Profit vs year ago compares with the same quarter a year earlier; – where that quarter is not on file or made a loss.
Download results (zip) A spreadsheet of the quarterly results and balance sheets, with the original filings from NSE.
Balance sheet
| As on | September 2026 |
|---|---|
| Fixed assets | ₹292 Cr |
| Investments | ₹63 Cr |
| Inventories | ₹330 Cr |
| Owed by customers | ₹318 Cr |
| Cash and equivalents | ₹78 Cr |
| Total assets | ₹1,326 Cr |
| Borrowings | ₹302 Cr |
| Total liabilities | ₹581 Cr |
| Shareholders’ equity | ₹737 Cr |
Source: Sahajanand Medical Technologies’s half-yearly statements of assets and liabilities filed with NSE, consolidated. Companies file these every September and March.
About Sahajanand Medical Technologies
Sahajanand Medical Technologies Limited engages in the manufacture and distribution of Class III and Class C/D medical devices in India, Europe, rest of the Asia Pacific, Latin America, and the Middle East and Africa. The company provides vascular intervention products coronary stents and balloons used to diagnose or treat diseases of the blood vessels; structural heart products comprising trans-catheter aortic valves and occluders used to treat defects or abnormalities in the heart's structure; and other products, such as renal stents, peripheral drug-coated balloon catheters, and other trading products. It also trades in and distributes medical devices/medical implants; and surgical, hospital, pharmaceutical, dental, laboratory, and orthopedic and traumatology products, materials, and equipment. The company was founded in 1999 and is headquartered in Surat, India.
- Industry
- Medical Devices
- Based in
- Surat
- Employees
- 1,605
Company website · Profile: Yahoo Finance
In the news
All newsNo headlines name Sahajanand Medical Technologies in the last day or two.
Dividends and corporate actions
All companiesNSE lists no dividends or other corporate actions for Sahajanand Medical Technologies.
Information only, not investment advice. Prices are delayed.